158 related articles for article (PubMed ID: 28532005)
1. Non-viral strategies for ocular gene delivery.
Oliveira AV; Rosa da Costa AM; Silva GA
Mater Sci Eng C Mater Biol Appl; 2017 Aug; 77():1275-1289. PubMed ID: 28532005
[TBL] [Abstract][Full Text] [Related]
2. Self-focusing therapeutic gene delivery with intelligent gene vector swarms: intra-swarm signalling through receptor transgene expression in targeted cells.
Tolmachov OE
Artif Intell Med; 2015 Jan; 63(1):1-6. PubMed ID: 25547266
[TBL] [Abstract][Full Text] [Related]
3. Treatment of ocular disorders by gene therapy.
Solinís MÁ; del Pozo-Rodríguez A; Apaolaza PS; Rodríguez-Gascón A
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):331-42. PubMed ID: 25536112
[TBL] [Abstract][Full Text] [Related]
4. Current status of gene delivery and gene therapy in lacrimal gland using viral vectors.
Selvam S; Thomas PB; Hamm-Alvarez SF; Schechter JE; Stevenson D; Mircheff AK; Trousdale MD
Adv Drug Deliv Rev; 2006 Nov; 58(11):1243-57. PubMed ID: 17056149
[TBL] [Abstract][Full Text] [Related]
5. Non-viral retinal gene therapy: a review.
Charbel Issa P; MacLaren RE
Clin Exp Ophthalmol; 2012; 40(1):39-47. PubMed ID: 21745262
[TBL] [Abstract][Full Text] [Related]
6. Controlling the kinetics of interferon transgene expression for improved gene therapy.
Watcharanurak K; Nishikawa M; Takahashi Y; Takakura Y
J Drug Target; 2012 Nov; 20(9):764-9. PubMed ID: 22994266
[TBL] [Abstract][Full Text] [Related]
7. Nonviral approaches satisfying various requirements for effective in vivo gene therapy.
Nishikawa M; Hashida M
Biol Pharm Bull; 2002 Mar; 25(3):275-83. PubMed ID: 11913519
[TBL] [Abstract][Full Text] [Related]
8. Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer.
Zhang Y; Schlachetzki F; Li JY; Boado RJ; Pardridge WM
Mol Vis; 2003 Oct; 9():465-72. PubMed ID: 14551536
[TBL] [Abstract][Full Text] [Related]
9. Targeted transgene expression in muller glia of normal and diseased retinas using lentiviral vectors.
Greenberg KP; Geller SF; Schaffer DV; Flannery JG
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1844-52. PubMed ID: 17389520
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of chitosan-mediated gene delivery through combination with phiC31 integrase.
Oliveira AV; Silva GA; Chung DC
Acta Biomater; 2015 Apr; 17():89-97. PubMed ID: 25600399
[TBL] [Abstract][Full Text] [Related]
11. Gene delivery using herpes simplex virus vectors.
Burton EA; Fink DJ; Glorioso JC
DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy vector design strategies for the treatment of cancer.
Dong JY; Woraratanadharm J
Future Oncol; 2005 Jun; 1(3):361-73. PubMed ID: 16556010
[TBL] [Abstract][Full Text] [Related]
13. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
[TBL] [Abstract][Full Text] [Related]
14. Gene Therapy with the Sleeping Beauty Transposon System.
Kebriaei P; Izsvák Z; Narayanavari SA; Singh H; Ivics Z
Trends Genet; 2017 Nov; 33(11):852-870. PubMed ID: 28964527
[TBL] [Abstract][Full Text] [Related]
15. Wide Awake and Ready to Move: 20 Years of Non-Viral Therapeutic Genome Engineering with the Sleeping Beauty Transposon System.
Hodge R; Narayanavari SA; Izsvák Z; Ivics Z
Hum Gene Ther; 2017 Oct; 28(10):842-855. PubMed ID: 28870121
[TBL] [Abstract][Full Text] [Related]
16. Long-term retinal transgene expression with FIV versus adenoviral vectors.
Loewen N; Leske DA; Cameron JD; Chen Y; Whitwam T; Simari RD; Teo WL; Fautsch MP; Poeschla EM; Holmes JM
Mol Vis; 2004 Apr; 10():272-80. PubMed ID: 15094709
[TBL] [Abstract][Full Text] [Related]
17. Sleeping Beauty transposition: from biology to applications.
Narayanavari SA; Chilkunda SS; Ivics Z; Izsvák Z
Crit Rev Biochem Mol Biol; 2017 Feb; 52(1):18-44. PubMed ID: 27696897
[TBL] [Abstract][Full Text] [Related]
18. Engineered Non-Viral Gene Vectors for Combination Cancer Therapy: A Review.
Zheng Q; Lin D; Lei L; Li X; Shi S
J Biomed Nanotechnol; 2017 Dec; 13(12):1565-1580. PubMed ID: 29490748
[TBL] [Abstract][Full Text] [Related]
19. [Developments in gene delivery vectors for ocular gene therapy].
Khabou H; Dalkara D
Med Sci (Paris); 2015 May; 31(5):529-37. PubMed ID: 26059304
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
